Focused on the adoption of genomics and broader omic approaches for next-generation sequencing (NGS) across both research and clinical markets. Skilled commercial experience managing commercial functions to ensure customer success and market expansion for NGS applications. Held international roles from the US to EMEA in operations, marketing and sales. Experienced in leading and building a cross-functional team working within a matrix organization. Enthusiastic about how genomics is pioneering change within healthcare and the positive impact that genomics will have on human health from the agricultural industry to the clinic. Specialties: Proven ability to lead strategic initiatives and assess business opportunities, implementation of new technologies, financial projections and budget management, technical expertise in scientific applications and processes, product development, sales opportunity and account management.
Vice President, EMEA Sales at Oxford Nanopore Technologies
MBA, Business